Drug Name |
Nafarelin |
Drug ID |
BADD_D01513 |
Description |
Nafarelin is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. |
Indications and Usage |
For treatment of central precocious puberty (true precocious puberty, GnRH-dependent precocious precocity, complete isosexual precocity) in children of both sexes and for the treatment of endometriosis. |
Marketing Status |
Prescription |
ATC Code |
H01CA02 |
DrugBank ID |
DB00666
|
KEGG ID |
D08241
|
MeSH ID |
D017274
|
PubChem ID |
25077405
|
TTD Drug ID |
D08WYM
|
NDC Product Code |
Not Available |
Synonyms |
Nafarelin | Synarel | RS-94991-298 | RS 94991 298 | RS94991298 | Nafarelin Acetate | Nafarelin Acetate, Hydrate | Nafarelin Monoacetate |